These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20373766)

  • 1. Antimicrobial activity of tryptanthrins in Escherichia coli.
    Bandekar PP; Roopnarine KA; Parekh VJ; Mitchell TR; Novak MJ; Sinden RR
    J Med Chem; 2010 May; 53(9):3558-65. PubMed ID: 20373766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antibacterial activity of aminosugar-functionalized intercalating agents.
    Shi W; Marcus SL; Lowary TL
    Carbohydr Res; 2010 Jan; 345(1):10-22. PubMed ID: 19926076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial action of prototypic amphipathic cationic decapeptides and their branched dimers.
    Dewan PC; Anantharaman A; Chauhan VS; Sahal D
    Biochemistry; 2009 Jun; 48(24):5642-57. PubMed ID: 19432402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ellipticines: correlation between in vitro DNA intercalation and physiological properties?
    Bertrand JR; Giacomoni PU
    Chemioterapia; 1985 Dec; 4(6):445-53. PubMed ID: 3938348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotoxicity of non-covalent interactions: DNA intercalators.
    Ferguson LR; Denny WA
    Mutat Res; 2007 Oct; 623(1-2):14-23. PubMed ID: 17498749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial effects of chitosan solution against Legionella pneumophila, Escherichia coli, and Staphylococcus aureus.
    Fujimoto T; Tsuchiya Y; Terao M; Nakamura K; Yamamoto M
    Int J Food Microbiol; 2006 Nov; 112(2):96-101. PubMed ID: 17045689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin.
    Bailly C; Riou JF; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M
    Biochemistry; 1997 Apr; 36(13):3917-29. PubMed ID: 9092822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frameshift mutations induced by four isomeric nitroacridines and their des-nitro counterpart in the lacZ reversion assay in Escherichia coli.
    Hoffmann GR; Yin CC; Terry CE; Ferguson LR; Denny WA
    Environ Mol Mutagen; 2006 Mar; 47(2):82-94. PubMed ID: 16180206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of the anti-mutagenic effect of genistein in Escherichia coli.
    Yang Y; Fix D
    Mutat Res; 2006 Aug; 600(1-2):193-206. PubMed ID: 16872640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of faecal and optimal growth conditions on in vitro pharmacodynamic activity of marbofloxacin against Escherichia coli.
    Pellet T; Gicquel-Bruneau M; Sanders P; Laurentie M
    Res Vet Sci; 2006 Jun; 80(3):324-35. PubMed ID: 16126240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity of N-alkylated disaccharide chitosan derivatives.
    Yang TC; Chou CC; Li CF
    Int J Food Microbiol; 2005 Jan; 97(3):237-45. PubMed ID: 15582734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transposon mutagenesis identifies genes which control antimicrobial drug tolerance in stationary-phase Escherichia coli.
    Hu Y; Coates AR
    FEMS Microbiol Lett; 2005 Feb; 243(1):117-24. PubMed ID: 15668009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between structure and diverse biological activities of "half-mustard type" phenothiazines.
    Motohashi N; Kurihara T; Satoh K; Sakagami H; Molnár J
    Anticancer Res; 1997; 17(6D):4403-6. PubMed ID: 9494541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, cytotoxicity, QSAR, and intercalation study of new diindenopyridine derivatives.
    Miri R; Javidnia K; Hemmateenejad B; Azarpira A; Amirghofran Z
    Bioorg Med Chem; 2004 May; 12(10):2529-36. PubMed ID: 15110835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of monascus pigment derivatives on the electrophoretic mobility of bacteria, and the cell adsorption and antibacterial activities of pigments.
    Kim C; Jung H; Kim JH; Shin CS
    Colloids Surf B Biointerfaces; 2006 Feb; 47(2):153-9. PubMed ID: 16423514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial dendrimer active against Escherichia coli biofilms.
    Hou S; Zhou C; Liu Z; Young AW; Shi Z; Ren D; Kallenbach NR
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5478-81. PubMed ID: 19682902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCR-based site-specific mutagenesis of peptide antibiotics FALL-39 and its biologic activities.
    Yang YX; Feng Y; Wang BY; Wu Q
    Acta Pharmacol Sin; 2004 Feb; 25(2):239-45. PubMed ID: 14769216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, structure and antibacterial activity of novel 1-(5-substituted-3-substituted-4,5-dihydropyrazol-1-yl)ethanone oxime ester derivatives.
    Liu XH; Cui P; Song BA; Bhadury PS; Zhu HL; Wang SF
    Bioorg Med Chem; 2008 Apr; 16(7):4075-82. PubMed ID: 18262793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers.
    Ponte C; Gracia M; Giménez MJ; Aguilar L; Maín CM; Carpintero Y; Huelves L; Carcas A; del Prado G; Soriano F
    Clin Ther; 2005 Jul; 27(7):1043-9. PubMed ID: 16154483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition by the DNA repair system of DNA structural alterations induced by reversible drug-DNA interactions.
    Lambert B; Segal-Bendirdjian E; Esnault C; Le Pecq JB; Roques BP; Jones B; Yeung AT
    Anticancer Drug Des; 1990 Feb; 5(1):43-53. PubMed ID: 2180423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.